Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Haematology|December 23, 2004
Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogeneic stem cell transplantation: platelet is a major source of serum sCD40LMasayuki Nagasawa, Yi Zhu, Takeshi Isoda, et al.
European Journal of Haematology|September 10, 2017
Effect of reduced-intensity conditioning and the risk of late-onset non-infectious pulmonary complications in pediatric patientsMasayuki Nagasawa, Noriko Mitsuiki, Yuki Aoki, et al.
American Journal of Hematology|April 22, 2006
Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reactionMasayuki Nagasawa, Takeshi Isoda, Sukeyuki Itoh, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|February 4, 2025
Monitoring measurable residual disease in NUP98::NSD1-positive acute myeloid leukemiaIkuo Okuchi, Akira Nishimura, Takahiro Kamiya, et al.
Blood|June 20, 2012
Process for immune defect and chromosomal translocation during early thymocyte development lacking ATMTakeshi Isoda, Masatoshi Takagi, Jinhua Piao, et al.
Contrast Media & Molecular Imaging|June 30, 2010
Serine- and mannose-modified liposomal contrast agent for computed tomography: evaluation of the enhancement in rabbit liver VX-2 tumor modelMasahiro Okada, Takeshi Isoda, Seishi Kumano, et al.
The Journal of Antibiotics|July 13, 2006
Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084Takeshi Isoda, Hideki Ushirogochi, Koichi Satoh, et al.
Frontiers in Immunology|December 12, 2022
Case report: Optimized ruxolitinib-based therapy in an infant with familial hemophagocytic lymphohistiocytosis type 3Daiki Niizato, Takeshi Isoda, Noriko Mitsuiki, et al.
Pediatric Blood & Cancer|December 27, 2023
Transient erythroblastopenia due to a GATA1 variant in an infant femaleMotoi Yamashita, Takahiro Tomoda, Ami Mizuo, et al.
International Journal of Hematology|October 2, 2013
Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experienceMasayuki Nagasawa, Teppei Ohkawa, Akifumi Endo, et al.
Pageof 5